Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Hill

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Probing biological nanotopology via diffusion of weakly constrained plasmonic nanorods with optical coherence tomographyRaghav K Chhetri, Richard L Blackmon, Wei-Chen Wu, et al.
Ultrasound in Medicine & Biology|March 10, 2026
Inhalable Ultrasound Contrast Agent with Induced Microbubble Destruction and Associated Biological Effects on the Respiratory Epithelium, In VitroAndrew S Weitz, Patrick R Sears, Phillip W Clapp, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2017
Sialic acid-to-urea ratio as a measure of airway surface hydrationCharles R Esther, David B Hill, Brian Button, et al.
Nucleic Acid Therapeutics|August 29, 2023
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis PatientsEfrat Ozeri-Galai, Lital Friedman, Ofra Barchad-Avitzur, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2006
A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilmsHirotoshi Matsui, Victoria E Wagner, David B Hill, et al.
Scientific Reports|December 1, 2024
Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imagingJames K Tsuruta, Patrick R Sears, Meghan E Rebuli, et al.
Plos One|February 22, 2014
A biophysical basis for mucus solids concentration as a candidate biomarker for airways diseaseDavid B Hill, Paula A Vasquez, John Mellnik, et al.
The European Respiratory Journal|October 27, 2018
Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pHDavid B Hill, Robert F Long, William J Kissner, et al.
Mbio|April 23, 2024
Mucus polymer concentration and <i>in vivo</i> adaptation converge to define the antibiotic response of <i>Pseudomonas aeruginosa</i> during chronic lung infectionMatthew A Greenwald, Suzanne L Meinig, Lucas M Plott, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Mucus polymer concentration and <i>in vivo</i> adaptation converge to define the antibiotic response of <i>Pseudomonas aeruginosa</i> during chronic lung infectionMatthew A Greenwald, Suzanne L Meinig, Lucas M Plott, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Probing biological nanotopology via diffusion of weakly constrained plasmonic nanorods with optical coherence tomographyRaghav K Chhetri, Richard L Blackmon, Wei-Chen Wu, et al.
Ultrasound in Medicine & Biology|March 10, 2026
Inhalable Ultrasound Contrast Agent with Induced Microbubble Destruction and Associated Biological Effects on the Respiratory Epithelium, In VitroAndrew S Weitz, Patrick R Sears, Phillip W Clapp, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2017
Sialic acid-to-urea ratio as a measure of airway surface hydrationCharles R Esther, David B Hill, Brian Button, et al.
Nucleic Acid Therapeutics|August 29, 2023
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis PatientsEfrat Ozeri-Galai, Lital Friedman, Ofra Barchad-Avitzur, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2006
A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilmsHirotoshi Matsui, Victoria E Wagner, David B Hill, et al.
Scientific Reports|December 1, 2024
Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imagingJames K Tsuruta, Patrick R Sears, Meghan E Rebuli, et al.
Plos One|February 22, 2014
A biophysical basis for mucus solids concentration as a candidate biomarker for airways diseaseDavid B Hill, Paula A Vasquez, John Mellnik, et al.
The European Respiratory Journal|October 27, 2018
Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pHDavid B Hill, Robert F Long, William J Kissner, et al.
Mbio|April 23, 2024
Mucus polymer concentration and <i>in vivo</i> adaptation converge to define the antibiotic response of <i>Pseudomonas aeruginosa</i> during chronic lung infectionMatthew A Greenwald, Suzanne L Meinig, Lucas M Plott, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Mucus polymer concentration and <i>in vivo</i> adaptation converge to define the antibiotic response of <i>Pseudomonas aeruginosa</i> during chronic lung infectionMatthew A Greenwald, Suzanne L Meinig, Lucas M Plott, et al.
Pageof 7